Target Audience:
This activity is intended for the internist and family practitioner.Accreditation:
AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Credit Designation:
AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Subjects:
- Even If You Use It, You May Lose It!
- Effect of a New Diagnosis of Barrett’s Esophagus on Insurance Status
- Increased Dietary Intake of Folate Reduces the Risk of Developing Alzheimer’s Disease
- Pharmacology Update: Ramelteon Tablets (Rozerem™)
- Clinical Briefs
- ECG Review: When Did the Chest Pain Begin?
Objectives:
- Describe new findings in differential diagnosis and treatment of various diseases
- Describe controversies, advantages, and disadvantages of those advances
- Describe cost-effective treatment regimens
Financial Disclosure:
Internal Medicine Alert’s Editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca and serves on the speaker’s bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil.